Maria Pia Sormani

InstitutionUniversity of Genoa
AddressGenoa
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 13 Covid-19 publications, with a maximum of 4 publications in July 2021
    All Publications
    Bar chart showing 308 publications over 26 distinct years, with a maximum of 30 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Sormani MP, Schiavetti I, Landi D, Carmisciano L, De Rossi N, Cordioli C, Moiola L, Radaelli M, Immovilli P, Capobianco M, Brescia Morra V, Trojano M, Tedeschi G, Comi G, Battaglia MA, Patti F, Fragoso YD, Sen S, Siva A, Furlan R, Salvetti M. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study. Mult Scler. 2021 Jul 30; 13524585211035318. PMID: 34328824.
      Citations: 8     Fields:    
    2. Fragoso YD, Schiavetti I, Carmisciano L, Ponzano M, Steinberg J, Treviño-Frenk I, Ciampi E, Vecino MCA, Correa EP, Carcamo C, Gomes S, Pimentel MLV, Santos GAC, Vrech C, Winckler TCA, Sormani MP. Coronavirus disease 2019 in Latin American patients with multiple sclerosis. Mult Scler Relat Disord. 2021 Oct; 55:103173. PMID: 34332462.
      Citations:    Fields:    Translation:HumansPHPublic Health
    3. Landi D, Ponzano M, Nicoletti CG, Cola G, Cecchi G, Grimaldi A, Mataluni G, Mercuri NB, Sormani MP, Pacileo G, Marfia GA. Patient's point of view on the use of telemedicine in multiple sclerosis: a web-based survey. Neurol Sci. 2022 Feb; 43(2):1197-1205. PMID: 34283343.
      Citations:    Fields:    
    4. Sormani MP, Salvetti M, Labauge P, Schiavetti I, Zephir H, Carmisciano L, Bensa C, De Rossi N, Pelletier J, Cordioli C, Vukusic S, Moiola L, Kerschen P, Radaelli M, Théaudin M, Immovilli P, Casez O, Capobianco M, Ciron J, Trojano M, Stankoff B, Créange A, Tedeschi G, Clavelou P, Comi G, Thouvenot E, Battaglia MA, Moreau T, Patti F, De Sèze J, Louapre C. DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France. Ann Clin Transl Neurol. 2021 08; 8(8):1738-1744. PMID: 34240579.
      Citations: 10     Fields:    Translation:Humans
    5. Sen S, Karabudak R, Schiavetti I, Demir S, Ozakbas S, Tutuncu M, Petek Balci B, Turan OF, Uzunkopru C, Koseoglu M, Yetkin MF, Gunduz T, Gumus H, Kale Icen N, Carmisciano L, Terzi M, Acar P, Gungor Dogan I, Baba C, Tuncer A, Uygunoglu U, Sormani MP, Efendi H, Siva A. The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals? Mult Scler Relat Disord. 2021 Jul; 52:102968. PMID: 33940495.
      Citations: 3     Fields:    Translation:Humans
    6. Sukkar SG, Cogorno L, Pisciotta L, Pasta A, Vena A, Gradaschi R, Dentone C, Guiddo E, Martino E, Beltramini S, Donini LM, Carmisciano L, Sormani MP, Bassetti M. Clinical efficacy of eucaloric ketogenic nutrition in the COVID-19 cytokine storm: A retrospective analysis of mortality and intensive care unit admission. Nutrition. 2021 09; 89:111236. PMID: 33895559.
      Citations: 5     Fields:    Translation:Humans
    7. Sormani MP, De Rossi N, Schiavetti I, Carmisciano L, Cordioli C, Moiola L, Radaelli M, Immovilli P, Capobianco M, Trojano M, Zaratin P, Tedeschi G, Comi G, Battaglia MA, Patti F, Salvetti M. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis. Ann Neurol. 2021 04; 89(4):780-789. PMID: 33480077.
      Citations: 63     Fields:    Translation:Humans
    8. Pontali E, Volpi S, Signori A, Antonucci G, Castellaneta M, Buzzi D, Montale A, Bustaffa M, Angelelli A, Caorsi R, Giambruno E, Bobbio N, Feasi M, Gueli I, Tricerri F, Calautti F, Castagnola E, Moscatelli A, Rollandi GA, Ravelli A, Cassola G, Sormani MP, Gattorno M. Efficacy of early anti-inflammatory treatment with high doses of intravenous anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia. J Allergy Clin Immunol. 2021 04; 147(4):1217-1225. PMID: 33556464.
      Citations: 13     Fields:    Translation:HumansPHPublic Health
    9. Laroni A, Schiavetti I, Sormani MP, Uccelli A. COVID-19 in patients with multiple sclerosis undergoing disease-modifying treatments. Mult Scler. 2021 12; 27(14):2126-2136. PMID: 33205695.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    10. Citations: 33     Fields:    Translation:HumansCellsPHPublic Health
    11. Landi D, Ponzano M, Nicoletti CG, Cecchi G, Cola G, Mataluni G, Mercuri NB, Sormani MP, Marfia GA. Adherence to social distancing and use of personal protective equipment and the risk of SARS-CoV-2 infection in a cohort of patients with multiple sclerosis. Mult Scler Relat Disord. 2020 Oct; 45:102359. PMID: 32663793.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    12. Capra R, De Rossi N, Mattioli F, Romanelli G, Scarpazza C, Sormani MP, Cossi S. Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia. Eur J Intern Med. 2020 06; 76:31-35. PMID: 32405160.
      Citations: 106     Fields:    Translation:HumansCellsPHPublic Health
    13. Sormani MP. An Italian programme for COVID-19 infection in multiple sclerosis. Lancet Neurol. 2020 06; 19(6):481-482. PMID: 32359409.
      Citations: 95     Fields:    Translation:HumansCellsPHPublic Health
    Sormani's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (233)
    Explore
    _
    Co-Authors (170)
    Explore
    _
    Similar People (60)
    Explore
    _